THALIA THERAPEUTICS PLC (THAT) — Investor Presentation

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Thalia Therapeutics Plc.

Watch the replay

Replay transcript excerpt

WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a0430f-7aff-7ea0-8626-89b210a473e7 Created: 2026-08-27T11:51:29.749Z Duration: 2681.936 Channels: 1 00:00:00.799 -- 00:00:03.280 Good afternoon, and welcome to the THALIA THERAPEUTICS 00:00:03.280 -- 00:00:04.880 PLC Investor Presentation. 00:00:05.120 -- 00:00:07.440 Throughout this recorded presentation, investors will be in 00:00:07.440 -- 00:00:09.760 listen only mode. Questions are encouraged and could 00:00:09.760 -- 00:00:11.360 be submitted at any time via the Q 00:00:11.360 -- 00:00:12.799 and A tab situated on the right hand 00:00:12.799 -- 00:00:14.715 corner of your screen. Simply type in your 00:00:14.715 -- 00:00:16.955 questions and press send. The company may not 00:00:16.955 -- 00:00:18.475 be in a position to answer every question 00:00:18.475 -- 00:00:20.715 it receives during the meeting itself. However, the 00:00:20.715 -- 00:00:22.795 company can review all questions submitted today and 00:00:22.795 -- 00:00:25.115 publish responses where it's appropriate to do so. 00:00:25.275 -- 00:00:26.875 Before we begin, I'd like to submit the 00:00:26.875 -- 00:00:28.810 following poll. I'd now like to hand you 00:00:28.810 -- 00:00:31.610 over to David Solomon, CEO. Good afternoon, sir. 00:00:32.330 -- 00:00:34.090 Thank you so much for the introduction, and 00:00:34.090 -- 00:00:36.170 thank you all for your attendance today. I'm 00:00:36.170 -- 00:00:38.970 David Solomon. I'm the relatively new CEO of 00:00:38.970 -- 00:00:40.090 THALIA THERAPEUTICS, 00:00:40.305 -- 00:00:42.145 and I'm delighted to be here today to 00:00:42.145 -- 00:00:44.705 tell you about our innovative RNA therapeutics, 00:00:44.865 -- 00:00:45.585 programs. 00:00:46.145 -- 00:00:49.025 This is our usual, safe harbor dis...